Androgenetic alopecia treated with topical minoxidil

J Am Acad Dermatol. 1987 Mar;16(3 Pt 2):669-72. doi: 10.1016/s0190-9622(87)70085-1.

Abstract

A randomized double-blind trial of topical minoxidil was carried out during a 12-month period in 56 patients with male pattern baldness. Subjects were randomly assigned to treatment with either 2% minoxidil solution, 3% minoxidil solution, or placebo. The placebo group was switched to 3% minoxidil after the first 4 months. Subjects using the 2% and 3% solutions of minoxidil showed a significant change in terminal and indeterminate hair counts (p less than 0.05) from the placebo group at 4 months. A progressive decrease in vellus hair counts with a concomitant increase in both indeterminate and terminal hair counts was noted during the 12-month period, suggesting that minoxidil applied topically partially reverses the balding phenomenon.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Administration, Topical
  • Alopecia / drug therapy*
  • Clinical Trials as Topic
  • Double-Blind Method
  • Humans
  • Male
  • Minoxidil / therapeutic use*
  • Random Allocation

Substances

  • Minoxidil